Variantyx

Framingham, United States

Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.

$36.0M raised

Apr 2024

Series D

Top Investors

Bosch VenturesPitango VCNew Era Capital PartnersKreos CapitalPeregrine Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Variantyx raised?

Variantyx has raised $36.0M in total funding. The most recent round was Series D. The last funding was announced in April 2024.

Who are Variantyx's investors?

Variantyx's investors include Bosch Ventures, Pitango VC, New Era Capital Partners, Kreos Capital, Peregrine Ventures.

Where is Variantyx headquartered?

Variantyx is headquartered in Framingham, United States.

What does Variantyx do?

Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.

What stage is Variantyx at?

Variantyx is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 26, 2024.

MLA

"Variantyx — Funding & Investors." VCBacked, April 26, 2024, https://www.vcbacked.co/company/variantyx. Accessed June 16, 2026.

APA

VCBacked. (2024). Variantyx — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/variantyx

Wikipedia (cite web)

{{cite web |title=Variantyx — Funding & Investors |url=https://www.vcbacked.co/company/variantyx |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 26, 2024.